Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279479 Method for the treatment of heart failure
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279293 Constitutively active histamine H3 receptor mutants and uses thereof
10/09/2007US7279180 Combine solutions of each vitamin, i.e, K, D's, E and A, in water or an inert oil and emulsify using a protective colloid; drying; fineness; discoloration inhibition; homogeneity; oxidation resistance
10/09/2007CA2529400C Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/06/2007WO2008125901A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
10/04/2007WO2007112402A1 Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
10/04/2007WO2007111921A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007WO2007111806A2 Cyclopentane heptanoic acid compounds for reducing body fat
10/04/2007WO2007111306A1 Lipid metabolism ameliorating agent
10/04/2007WO2007111276A1 Novel ester derivative and use thereof
10/04/2007WO2007111242A1 Ameliorating agent for metabolic syndrome
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2007111027A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007WO2007110730A2 Varenicline standards and impurity controls
10/04/2007WO2007110297A1 Healthy food product
10/04/2007WO2007110296A1 Healthy food product
10/04/2007WO2007110225A1 Improved crystalline material
10/04/2007WO2007110216A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007110215A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007109929A1 The medicament for treating hyperphospheremia and preparation thereof
10/04/2007WO2007109884A1 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
10/04/2007WO2007109882A1 Anti-diabetic cataract compounds and their uses
10/04/2007WO2007109845A1 Prophylaxis or treatment of diabetes
10/04/2007WO2007095601A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
10/04/2007WO2007082309A3 Adenosine monophosphate for inducing torpor in a subject
10/04/2007WO2007075847A3 Glucokinase activators
10/04/2007WO2007067964B1 Mucosal delivery of stabilized formulations of exendin
10/04/2007WO2007063385A3 Spirocyclic amine histamine-3 receptor antagonists
10/04/2007WO2007060525A3 Process for preparing bicyclic pyrazolyl and imidazolyl compounds
10/04/2007WO2007049137A3 Canola extracts containing high levels of sinapic acid
10/04/2007WO2006131836A3 Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007US20070232647 Use of Ppar Agonists to Treat Ruminants
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232571 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
10/04/2007US20070232533 Use of Vinca Alkaloids and Salts Thereof
10/04/2007US20070231859 Novel scavenger receptor
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231404 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007DE102006014688A1 Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-3-one derivatives as inhibitors of lipases, and phospholipases
10/04/2007DE102006014685A1 Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen Imidazo-pyridin-2-one derivatives as inhibitors of lipases, and Phospholiphasen
10/04/2007DE102006014424A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes
10/04/2007DE102006014420A1 New 5-D-fructose dehydrogenase in combination with an enzyme, e.g. glucose isomerase, useful for preventing or treating adiposity
10/04/2007CA2681668A1 Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
10/04/2007CA2647425A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647422A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647237A1 Ingestible compositions containing extracts
10/04/2007CA2646704A1 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
10/04/2007CA2645487A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007CA2645281A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007CA2644585A1 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
10/04/2007CA2644488A1 Anti-diabetic cataract compounds and their uses
10/04/2007CA2644448A1 Varenicline standards and impurity controls
10/04/2007CA2642872A1 Improved crystalline material
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839663A1 Blood cholesterol reducing oral composition
10/03/2007EP1839661A2 Pipecolic acid-containing antidiabetic compositions
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1838710A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/03/2007EP1838706A1 G-protein coupled receptor agonists
10/03/2007EP1838698A1 Pyrimidine derivatives as gpcr agonists
10/03/2007EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
10/03/2007EP1838687A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838686A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838685A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838684A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838677A2 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
10/03/2007EP1838662A1 Squaric acid derivatives
10/03/2007EP1838311A1 G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
10/03/2007EP1838292A1 Preparation for preventing or treating calcium deficiency conditions in mammals
10/03/2007EP1838172A1 Novel nutraceutical compositions
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament
10/03/2007EP1549638B1 Indole-3-carboxamides as glucokinase (gk) activators
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1298